1 Prostate Cancer Diagnostics Market Overview 1.1 Prostate Cancer Diagnostics Product Scope 1.2 Prostate Cancer Diagnostics Segment by Type 1.2.1 Global Prostate Cancer Diagnostics Sales by Type (2020-2026) 1.2.2 Tumor Biomarker Tests 1.2.3 Imaging 1.2.4 Biopsy 1.2.5 Other 1.3 Prostate Cancer Diagnostics Segment by Application 1.3.1 Global Prostate Cancer Diagnostics Sales Comparison by Application (2020-2026) 1.3.2 age < 55 1.3.3 age 55-75 1.3.4 age > 75 1.4 Prostate Cancer Diagnostics Market Estimates and Forecasts (2015-2026) 1.4.1 Global Prostate Cancer Diagnostics Sales Growth Rate (2015-2026) 1.4.2 Global Prostate Cancer Diagnostics Revenue and Growth Rate (2015-2026) 1.4.3 Global Prostate Cancer Diagnostics Price Trends (2015-2026) 2 Prostate Cancer Diagnostics Estimate and Forecast by Region 2.1 Global Prostate Cancer Diagnostics Market Size by Region: 2015 VS 2020 VS 2026 2.2 Global Prostate Cancer Diagnostics Retrospective Market Scenario by Region (2015-2020) 2.2.1 Global Prostate Cancer Diagnostics Sales Market Share by Region (2015-2020) 2.2.2 Global Prostate Cancer Diagnostics Revenue Market Share by Region (2015-2020) 2.3 Global Prostate Cancer Diagnostics Market Estimates and Forecasts by Region (2021-2026) 2.3.1 Global Prostate Cancer Diagnostics Sales Estimates and Forecasts by Region (2021-2026) 2.3.2 Global Prostate Cancer Diagnostics Revenue Forecast by Region (2021-2026) 2.4 Geographic Market Analysis: Market Facts & Figures 2.4.1 United States Prostate Cancer Diagnostics Estimates and Projections (2015-2026) 2.4.2 Europe Prostate Cancer Diagnostics Estimates and Projections (2015-2026) 2.4.3 China Prostate Cancer Diagnostics Estimates and Projections (2015-2026) 2.4.4 Japan Prostate Cancer Diagnostics Estimates and Projections (2015-2026) 2.4.5 Southeast Asia Prostate Cancer Diagnostics Estimates and Projections (2015-2026) 2.4.6 India Prostate Cancer Diagnostics Estimates and Projections (2015-2026) 3 Global Prostate Cancer Diagnostics Competition Landscape by Players 3.1 Global Top Prostate Cancer Diagnostics Players by Sales (2015-2020) 3.2 Global Top Prostate Cancer Diagnostics Players by Revenue (2015-2020) 3.3 Global Prostate Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Cancer Diagnostics as of 2019) 3.4 Global Prostate Cancer Diagnostics Average Price by Company (2015-2020) 3.5 Manufacturers Prostate Cancer Diagnostics Manufacturing Sites, Area Served, Product Type 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3.7 Primary Interviews with Key Prostate Cancer Diagnostics Players (Opinion Leaders) 4 Global Prostate Cancer Diagnostics Market Size by Type 4.1 Global Prostate Cancer Diagnostics Historic Market Review by Type (2015-2020) 4.1.1 Global Prostate Cancer Diagnostics Sales Market Share by Type (2015-2020) 4.1.2 Global Prostate Cancer Diagnostics Revenue Market Share by Type (2015-2020) 4.1.3 Global Prostate Cancer Diagnostics Price by Type (2015-2020) 4.2 Global Prostate Cancer Diagnostics Market Estimates and Forecasts by Type (2021-2026) 4.2.1 Global Prostate Cancer Diagnostics Sales Forecast by Type (2021-2026) 4.2.2 Global Prostate Cancer Diagnostics Revenue Forecast by Type (2021-2026) 4.2.3 Global Prostate Cancer Diagnostics Price Forecast by Type (2021-2026) 5 Global Prostate Cancer Diagnostics Market Size by Application 5.1 Global Prostate Cancer Diagnostics Historic Market Review by Application (2015-2020) 5.1.1 Global Prostate Cancer Diagnostics Sales Market Share by Application (2015-2020) 5.1.2 Global Prostate Cancer Diagnostics Revenue Market Share by Application (2015-2020) 5.1.3 Global Prostate Cancer Diagnostics Price by Application (2015-2020) 5.2 Global Prostate Cancer Diagnostics Market Estimates and Forecasts by Application (2021-2026) 5.2.1 Global Prostate Cancer Diagnostics Sales Forecast by Application (2021-2026) 5.2.2 Global Prostate Cancer Diagnostics Revenue Forecast by Application (2021-2026) 5.2.3 Global Prostate Cancer Diagnostics Price Forecast by Application (2021-2026) 6 United States Prostate Cancer Diagnostics Market Facts & Figures 6.1 United States Prostate Cancer Diagnostics Sales Market Share by Company (2015-2020) 6.2 United States Prostate Cancer Diagnostics Sales Market Share by Type (2015-2020) 6.3 United States Prostate Cancer Diagnostics Sales Market Share by Application (2015-2020) 7 Europe Prostate Cancer Diagnostics Market Facts & Figures 7.1 Europe Prostate Cancer Diagnostics Sales Market Share by Company (2015-2020) 7.2 Europe Prostate Cancer Diagnostics Sales Market Share by Type (2015-2020) 7.3 Europe Prostate Cancer Diagnostics Sales Market Share by Application (2015-2020) 8 China Prostate Cancer Diagnostics Market Facts & Figures 8.1 China Prostate Cancer Diagnostics Sales Market Share by Company (2015-2020) 8.2 China Prostate Cancer Diagnostics Sales Market Share by Type (2015-2020) 8.3 China Prostate Cancer Diagnostics Sales Market Share by Application (2015-2020) 9 Japan Prostate Cancer Diagnostics Market Facts & Figures 9.1 Japan Prostate Cancer Diagnostics Sales Market Share by Company (3015-3030) 9.2 Japan Prostate Cancer Diagnostics Sales Market Share by Type (2015-2020) 9.3 Japan Prostate Cancer Diagnostics Sales Market Share by Application (2015-2020) 10 Southeast Asia Prostate Cancer Diagnostics Market Facts & Figures 10.1 Southeast Asia Prostate Cancer Diagnostics Sales Market Share by Company (2015-2020) 10.2 Southeast Asia Prostate Cancer Diagnostics Sales Market Share by Type (2015-2020) 10.3 Southeast Asia Prostate Cancer Diagnostics Sales Market Share by Application (2015-2020) 11 India Prostate Cancer Diagnostics Market Facts & Figures 11.1 India Prostate Cancer Diagnostics Sales Market Share by Company (2015-2020) 11.2 India Prostate Cancer Diagnostics Sales Market Share by Type (2015-2020) 11.3 India Prostate Cancer Diagnostics Sales Market Share by Application (2015-2020) 12 Company Profiles and Key Figures in Prostate Cancer Diagnostics Business 12.1 Genomic Health 12.1.1 Genomic Health Corporation Information 12.1.2 Genomic Health Business Overview 12.1.3 Genomic Health Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020) 12.1.4 Genomic Health Prostate Cancer Diagnostics Products Offered 12.1.5 Genomic Health Recent Development 12.2 Abbott 12.2.1 Abbott Corporation Information 12.2.2 Abbott Business Overview 12.2.3 Abbott Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020) 12.2.4 Abbott Prostate Cancer Diagnostics Products Offered 12.2.5 Abbott Recent Development 12.3 OPKO 12.3.1 OPKO Corporation Information 12.3.2 OPKO Business Overview 12.3.3 OPKO Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020) 12.3.4 OPKO Prostate Cancer Diagnostics Products Offered 12.3.5 OPKO Recent Development 12.4 Siemens Healthcare 12.4.1 Siemens Healthcare Corporation Information 12.4.2 Siemens Healthcare Business Overview 12.4.3 Siemens Healthcare Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020) 12.4.4 Siemens Healthcare Prostate Cancer Diagnostics Products Offered 12.4.5 Siemens Healthcare Recent Development 12.5 DiaSorin 12.5.1 DiaSorin Corporation Information 12.5.2 DiaSorin Business Overview 12.5.3 DiaSorin Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020) 12.5.4 DiaSorin Prostate Cancer Diagnostics Products Offered 12.5.5 DiaSorin Recent Development 12.6 BioMeriux 12.6.1 BioMeriux Corporation Information 12.6.2 BioMeriux Business Overview 12.6.3 BioMeriux Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020) 12.6.4 BioMeriux Prostate Cancer Diagnostics Products Offered 12.6.5 BioMeriux Recent Development 12.7 Roche 12.7.1 Roche Corporation Information 12.7.2 Roche Business Overview 12.7.3 Roche Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020) 12.7.4 Roche Prostate Cancer Diagnostics Products Offered 12.7.5 Roche Recent Development 12.8 MDx Health 12.8.1 MDx Health Corporation Information 12.8.2 MDx Health Business Overview 12.8.3 MDx Health Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020) 12.8.4 MDx Health Prostate Cancer Diagnostics Products Offered 12.8.5 MDx Health Recent Development 12.9 Beckman Coulter 12.9.1 Beckman Coulter Corporation Information 12.9.2 Beckman Coulter Business Overview 12.9.3 Beckman Coulter Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020) 12.9.4 Beckman Coulter Prostate Cancer Diagnostics Products Offered 12.9.5 Beckman Coulter Recent Development 12.10 Myriad Genetics 12.10.1 Myriad Genetics Corporation Information 12.10.2 Myriad Genetics Business Overview 12.10.3 Myriad Genetics Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020) 12.10.4 Myriad Genetics Prostate Cancer Diagnostics Products Offered 12.10.5 Myriad Genetics Recent Development 12.11 Ambry Genetics 12.11.1 Ambry Genetics Corporation Information 12.11.2 Ambry Genetics Business Overview 12.11.3 Ambry Genetics Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020) 12.11.4 Ambry Genetics Prostate Cancer Diagnostics Products Offered 12.11.5 Ambry Genetics Recent Development 13 Prostate Cancer Diagnostics Manufacturing Cost Analysis 13.1 Prostate Cancer Diagnostics Key Raw Materials Analysis 13.1.1 Key Raw Materials 13.1.2 Key Raw Materials Price Trend 13.1.3 Key Suppliers of Raw Materials 13.2 Proportion of Manufacturing Cost Structure 13.3 Manufacturing Process Analysis of Prostate Cancer Diagnostics 13.4 Prostate Cancer Diagnostics Industrial Chain Analysis 14 Marketing Channel, Distributors and Customers 14.1 Marketing Channel 14.2 Prostate Cancer Diagnostics Distributors List 14.3 Prostate Cancer Diagnostics Customers 15 Market Dynamics 15.1 Prostate Cancer Diagnostics Market Trends 15.2 Prostate Cancer Diagnostics Opportunities and Drivers 15.3 Prostate Cancer Diagnostics Market Challenges 15.4 Prostate Cancer Diagnostics Market Restraints 15.5 Porter's Five Forces Analysis 16 Research Findings and Conclusion 17 Appendix 17.1 Research Methodology 17.1.1 Methodology/Research Approach 17.1.2 Data Source 17.2 Author List 17.3 Disclaimer

List of Tables Table 1. Global Prostate Cancer Diagnostics Sales (K Units) Growth Rate by Type (2020-2026) (US$ Million) Table 2. Global Prostate Cancer Diagnostics Sales (K Units) Comparison by Application (2020-2026) (US$ Million) Table 3. Global Market Prostate Cancer Diagnostics Market Size (US$ Million) by Region:2015 VS 2020 &2026 Table 4. Global Prostate Cancer Diagnostics Sales (K Units) by Region (2015-2020) Table 5. Global Prostate Cancer Diagnostics Sales Market Share by Region (2015-2020) Table 6. Global Prostate Cancer Diagnostics Revenue (US$ Million) Market Share by Region (2015-2020)) Table 7. Global Prostate Cancer Diagnostics Revenue Share by Region (2015-2020) Table 8. Global Prostate Cancer Diagnostics Sales (K Units) Forecast by Region (2021-2026) Table 9. Global Prostate Cancer Diagnostics Sales Market Share Forecast by Region (2021-2026) Table 10. Global Prostate Cancer Diagnostics Revenue (US$ Million) Forecast by Region (2021-2026) Table 11. Global Prostate Cancer Diagnostics Revenue Share Forecast by Region (2021-2026) Table 12. Global Prostate Cancer Diagnostics (K Units) of Key Companies (2015-2020) Table 13. Global Prostate Cancer Diagnostics Sales Share by Company (2015-2020) Table 14. Global Prostate Cancer Diagnostics Revenue (US$ Million) by Company (2015-2020) Table 15. Global Prostate Cancer Diagnostics Revenue Share by Company (2015-2020) Table 16. Global Prostate Cancer Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Cancer Diagnostics as of 2019) Table 17. Global Prostate Cancer Diagnostics Average Price (USD/Unit) of Key Company (2015-2020) Table 18. Manufacturers Prostate Cancer Diagnostics Manufacturing Sites and Area Served Table 19. Manufacturers Prostate Cancer Diagnostics Product Type Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans Table 21. Main Points Interviewed from Key Prostate Cancer Diagnostics Players Table 22. Global Prostate Cancer Diagnostics Sales (K Units) by Type (2015-2020) Table 23. Global Prostate Cancer Diagnostics Sales Share by Type (2015-2020) Table 24. Global Prostate Cancer Diagnostics Revenue (US$ Million) Market Share by Type (2015-2020) Table 25. Global Prostate Cancer Diagnostics Price (K Units) by Type (2015-2020) Table 26. Global Prostate Cancer Diagnostics Sales Share by Type (2021-2026) Table 27. Global Prostate Cancer Diagnostics Revenue (US$ Million) Market Share by Type (2021-2026) Table 28. Global Prostate Cancer Diagnostics Revenue Share by Type (2021-2026) Table 29. Global Prostate Cancer Diagnostics Price (K Units) by Type (2021-2026) Table 30. Global Prostate Cancer Diagnostics Sales (K Units) by Application (2015-2020) Table 31. Global Prostate Cancer Diagnostics Sales Share by Application (2015-2020) Table 32. Global Prostate Cancer Diagnostics Revenue (US$ Million) Market Share by Application (2015-2020) Table 33. Global Prostate Cancer Diagnostics Price (K Units) by Application (2015-2020) Table 34. Global Prostate Cancer Diagnostics Sales (K Units) by Application (2021-2026) Table 35. Global Prostate Cancer Diagnostics Sales Share by Application (2021-2026) Table 36. Global Prostate Cancer Diagnostics Revenue (US$ Million) Market Share by Application (2021-2026) Table 37. Global Prostate Cancer Diagnostics Revenue Share by Application (2021-2026) Table 38. Global Prostate Cancer Diagnostics Price (K Units) by Application (2021-2026) Table 39. United States Prostate Cancer Diagnostics Sales (K Units) by Company (2015-2020) Table 40. United States Prostate Cancer Diagnostics Sales Market Share by Company (2015-2020) Table 41. United States Prostate Cancer Diagnostics Sales (K Units) by Type (2015-2020) Table 42. United States Prostate Cancer Diagnostics Sales Market Share by Type (2015-2020) Table 43. United States Prostate Cancer Diagnostics Sales (K Units) by Application (2015-2020) Table 44. United States Prostate Cancer Diagnostics Sales Market Share by Application (2015-2020) Table 45. Europe Prostate Cancer Diagnostics Sales (K Units) by Company (2015-2020) Table 46. Europe Prostate Cancer Diagnostics Sales Market Share by Company (2015-2020) Table 47. Europe Prostate Cancer Diagnostics Sales (K Units) by Type (2015-2020) Table 48. Europe Prostate Cancer Diagnostics Sales Market Share by Type (2015-2020) Table 49. Europe Prostate Cancer Diagnostics Sales (K Units) by Application (2015-2020) Table 50. Europe Prostate Cancer Diagnostics Sales Market Share by Type (2015-2020) Table 51. China Prostate Cancer Diagnostics Sales (K Units) by Company (2015-2020) Table 52. China Prostate Cancer Diagnostics Sales Market Share by Company (2015-2020) Table 53. China Prostate Cancer Diagnostics Sales (K Units) by Type (2015-2020) Table 54. China Prostate Cancer Diagnostics Sales Market Share by Type (2015-2020) Table 55. China Prostate Cancer Diagnostics Sales (K Units) by Application (2015-2020) Table 56. China Prostate Cancer Diagnostics Sales Market Share by Application (2015-2020) Table 57. Japan Prostate Cancer Diagnostics Sales (K Units) by Company (2015-2020) Table 58. Japan Prostate Cancer Diagnostics Sales Market Share by Company (2015-2020) Table 59. Japan Prostate Cancer Diagnostics Sales (K Units) by Type (2015-2020) Table 60. Japan Prostate Cancer Diagnostics Sales Market Share by Type (2015-2020) Table 61. Japan Prostate Cancer Diagnostics Sales (K Units) by Application (2015-2020) Table 62. Japan Prostate Cancer Diagnostics Sales Market Share by Application (2015-2020) Table 63. Southeast Asia Prostate Cancer Diagnostics Sales (K Units) by Company (2015-2020) Table 64. Southeast Asia Prostate Cancer Diagnostics Sales Market Share by Company (2015-2020) Table 65. Southeast Asia Prostate Cancer Diagnostics Sales (K Units) by Type (2015-2020) Table 66. Southeast Asia Prostate Cancer Diagnostics Sales Market Share by Type (2015-2020) Table 67. Southeast Asia Prostate Cancer Diagnostics Sales (K Units) by Type (2015-2020) Table 68. Southeast Asia Prostate Cancer Diagnostics Sales Market Share by Application (2015-2020) Table 69. India Prostate Cancer Diagnostics Sales (K Units) by Company (2015-2020) Table 70. India Prostate Cancer Diagnostics Sales Market Share by Company (2015-2020) Table 71. India Prostate Cancer Diagnostics Sales (K Units) by Type (2015-2020) Table 72. India Prostate Cancer Diagnostics Sales Market Share by Type (2015-2020) Table 73. India Prostate Cancer Diagnostics Sales (K Units) by Application (2015-2020) Table 74. India Prostate Cancer Diagnostics Sales Market Share by Application (2015-2020) Table 75. Genomic Health Corporation Information Table 76. Genomic Health Description and Business Overview Table 77. Genomic Health Prostate Cancer Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 78. Genomic Health Prostate Cancer Diagnostics Product Table 79. Genomic Health Recent Development Table 80. Abbott Corporation Information Table 81. Abbott Description and Business Overview Table 82. Abbott Prostate Cancer Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 83. Abbott Prostate Cancer Diagnostics Product Table 84. Abbott Recent Development Table 85. OPKO Corporation Information Table 86. OPKO Description and Business Overview Table 87. OPKO Prostate Cancer Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 88. OPKO Prostate Cancer Diagnostics Product Table 89. OPKO Recent Development Table 90. Siemens Healthcare Corporation Information Table 91. Siemens Healthcare Description and Business Overview Table 92. Siemens Healthcare Prostate Cancer Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 93. Siemens Healthcare Prostate Cancer Diagnostics Product Table 94. Siemens Healthcare Recent Development Table 95. DiaSorin Corporation Information Table 96. DiaSorin Description and Business Overview Table 97. DiaSorin Prostate Cancer Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 98. DiaSorin Prostate Cancer Diagnostics Product Table 99. DiaSorin Recent Development Table 100. BioMeriux Corporation Information Table 101. BioMeriux Description and Business Overview Table 102. BioMeriux Prostate Cancer Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 103. BioMeriux Prostate Cancer Diagnostics Product Table 104. BioMeriux Recent Development Table 105. Roche Corporation Information Table 106. Roche Description and Business Overview Table 107. Roche Prostate Cancer Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 108. Roche Prostate Cancer Diagnostics Product Table 109. Roche Recent Development Table 110. MDx Health Corporation Information Table 111. MDx Health Prostate Cancer Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 112. MDx Health Description and Business Overview Table 113. MDx Health Prostate Cancer Diagnostics Product Table 114. MDx Health Recent Development Table 115. Beckman Coulter Corporation Information Table 116. Beckman Coulter Prostate Cancer Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 117. Beckman Coulter Description and Business Overview Table 118. Beckman Coulter Prostate Cancer Diagnostics Product Table 119. Beckman Coulter Recent Development Table 120. Myriad Genetics Corporation Information Table 121. Myriad Genetics Description and Business Overview Table 122. Myriad Genetics Prostate Cancer Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 123. Myriad Genetics Prostate Cancer Diagnostics Product Table 124. Myriad Genetics Recent Development Table 125. Ambry Genetics Corporation Information Table 126. Ambry Genetics Description and Business Overview Table 127. Ambry Genetics Prostate Cancer Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 128. Ambry Genetics Prostate Cancer Diagnostics Product Table 129. Ambry Genetics Recent Development Table 130. Production Base and Market Concentration Rate of Raw Material Table 131. Key Suppliers of Raw Materials Table 132. Prostate Cancer Diagnostics Distributors List Table 133. Prostate Cancer Diagnostics Customers List Table 134. Prostate Cancer Diagnostics Market Key Trends Table 135. Prostate Cancer Diagnostics Key Opportunities and Drivers Table 136. Prostate Cancer Diagnostics Market Challenges Table 137. Research Programs/Design for This Report Table 138. Key Data Information from Secondary Sources Table 139. Key Data Information from Primary Sources List of Figures Figure 1. Prostate Cancer Diagnostics Product Picture Figure 2. Global Prostate Cancer Diagnostics Sales Market Share by Type in 2020 & 2026 Figure 3. Type I Product Picture Figure 4. Type II Product Picture Figure 5. Global Prostate Cancer Diagnostics Market Share by Application in 2020 & 2026 Figure 6. age < 55 Examples Figure 7. age 55-75 Examples Figure 8. age > 75 Examples Figure 9. Global Prostate Cancer Diagnostics Sales (K Units) Growth Rate (2015-2026) Figure 10. Global Prostate Cancer Diagnostics Revenue (US$ Million) Growth Rate (2015-2026) Figure 11. Global Prostate Cancer Diagnostics Price Trends Growth Rate (2015-2026) (USD/Unit) Figure 12. Global Prostate Cancer Diagnostics Revenue Market Share by Region: 2015 VS 2020 Figure 13. Global Prostate Cancer Diagnostics Revenue Market Share by Region: 2021 VS 2026 Figure 14. United States Prostate Cancer Diagnostics Revenue (Million USD) Growth Rate (2015-2026) Figure 15. United States Prostate Cancer Diagnostics Sales (K Units) Growth Rate (2015-2026) Figure 16. Europe Prostate Cancer Diagnostics Revenue (Million USD) Growth Rate (2015-2026) Figure 17. Europe Prostate Cancer Diagnostics Sales (Million USD) Growth Rate (2015-2026) Figure 18. China Prostate Cancer Diagnostics Revenue (Million USD) Growth Rate (2015-2026) Figure 19. China Prostate Cancer Diagnostics Sales (Million USD) and Growth Rate (2015-2026) Figure 20. Japan Prostate Cancer Diagnostics Revenue (Million USD) Growth Rate (2015-2026) Figure 21. Japan Prostate Cancer Diagnostics Sales (Million USD) Growth Rate (2015-2026) Figure 22. Southeast Asia Prostate Cancer Diagnostics Revenue (Million USD) Growth Rate (2015-2026) Figure 23. Southeast Asia Prostate Cancer Diagnostics Sales (Million USD) Growth Rate (2015-2026) Figure 24. India Prostate Cancer Diagnostics Revenue (Million USD) Growth Rate (2015-2026) Figure 25. India Prostate Cancer Diagnostics Sales (Million USD) Growth Rate (2015-2026) Figure 26. Global 5 Largest Prostate Cancer Diagnostics Players Market Share by Revenue in Prostate Cancer Diagnostics 2015 & 2019 Figure 27. Prostate Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 28. Global Prostate Cancer Diagnostics Revenue Share by Type (2015-2020) Figure 29. Global Prostate Cancer Diagnostics Revenue Growth Rate by Type in 2015 & 2019 Figure 30. Global Prostate Cancer Diagnostics Revenue Share by Application (2015-2020) Figure 31. Global Prostate Cancer Diagnostics Revenue Growth Rate by Application in 2015 & 2019 Figure 32. United States Prostate Cancer Diagnostics Sales Market Share by Type in 2019 Figure 33. United States Prostate Cancer Diagnostics Sales Market Share by Type in 2019 Figure 34. Europe Prostate Cancer Diagnostics Sales Market Share by Company in 2019 Figure 35. Europe Prostate Cancer Diagnostics Sales Market Share by Type in 2019 Figure 36. Europe Prostate Cancer Diagnostics Sales Market Share by Application in 2019 Figure 37. China Prostate Cancer Diagnostics Sales Market Share by Company in 2019 Figure 38. China Prostate Cancer Diagnostics Sales Market Share by Type in 2019 Figure 39. China Prostate Cancer Diagnostics Sales Market Share by Application in 2019 Figure 40. Japan Prostate Cancer Diagnostics Sales Market Share by Company in 2019 Figure 41. Japan Prostate Cancer Diagnostics Sales Market Share by Type in 2019 Figure 42. Japan Prostate Cancer Diagnostics Sales Market Share by Application in 2019 Figure 43. Southeast Asia Prostate Cancer Diagnostics Sales Market Share by Company in 2019 Figure 44. Southeast Asia Prostate Cancer Diagnostics Sales Market Share by Type in 2019 Figure 45. Southeast Asia Prostate Cancer Diagnostics Sales Market Share by Application in 2019 Figure 46. India Prostate Cancer Diagnostics Sales Market Share by Company in 2019 Figure 47. India Prostate Cancer Diagnostics Sales Market Share by Type in 2019 Figure 48. India Prostate Cancer Diagnostics Sales Market Share by Application in 2019 Figure 49. Key Raw Materials Price Trend Figure 50. Manufacturing Cost Structure of Prostate Cancer Diagnostics Figure 51. Manufacturing Process Analysis of Prostate Cancer Diagnostics Figure 52. Prostate Cancer Diagnostics Industrial Chain Analysis Figure 53. Channels of Distribution Figure 54. Distributors Profiles Figure 55. Porter's Five Forces Analysis Figure 56. Bottom-up and Top-down Approaches for This Report Figure 57. Data Triangulation Figure 58. Key Executives Interviewed

Genomic Health Abbott OPKO Siemens Healthcare DiaSorin BioMeriux Roche MDx Health Beckman Coulter Myriad Genetics Ambry Genetics